Detalhe da pesquisa
1.
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(11): 1556, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582823
2.
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(3): 326-336, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778252
3.
Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments.
Immunity
; 55(6): 1118-1134.e8, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447093
4.
The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.
Cell
; 161(2): 319-32, 2015 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25843629
5.
Clinical trial links oncolytic immunoactivation to survival in glioblastoma.
Nature
; 623(7985): 157-166, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853118
6.
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma.
Nature
; 605(7910): 532-538, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508657
7.
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model.
Cell
; 148(4): 739-51, 2012 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22341446
8.
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.
Immunity
; 46(2): 197-204, 2017 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28228279
9.
MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8.
Blood
; 142(14): 1219-1232, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467575
10.
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.
Blood
; 141(15): 1817-1830, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706355
11.
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Nature
; 565(7738): 234-239, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568305
12.
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Mod Pathol
; 37(1): 100352, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839675
13.
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Ann Hematol
; 103(1): 185-198, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851072
14.
Essential role for TRPC5 in amygdala function and fear-related behavior.
Cell
; 137(4): 761-72, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19450521
15.
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma.
Nature
; 555(7696): 402, 2018 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29542692
16.
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma.
Blood
; 137(5): 637-645, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870269
17.
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.
Blood
; 137(23): 3212-3217, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720354
18.
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Blood
; 137(10): 1353-1364, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871584
19.
An immunogenic personal neoantigen vaccine for patients with melanoma.
Nature
; 547(7662): 217-221, 2017 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28678778
20.
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 23(2): 279-291, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033226